Navigation Links
CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
Date:5/17/2012

BOSTON and HONG KONG, May 17, 2012 /PRNewswire/ -- Ventac Partners and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH) today announced the creation of CASiGEN Pharma Ltd. (CASiGEN) to bring new treatments for diabetes and other metabolic disorders to the global market. CASiGEN received a world-wide exclusive license from GIBH that gives it access to new drug candidates addressing unmet medical needs in this field. CASiGEN is currently seeking investors to advance development of selected orally available small molecules targeting the ERR-alpha receptor as a potential diabetes treatment. The Company will apply to join the Hong Kong Science & Technology Parks (HKSTP), a world class research park based in Hong Kong and within the Guangzhou region.

(Logo: http://photos.prnewswire.com/prnh/20120517/NE09478LOGO )

Commenting about the license agreement, Dr. Duanqing Pei, Director General at GIBH, said: "The license agreement with CASiGEN Pharma constitutes an important milestone for GIBH as it takes a key research project to the global market in collaboration with an international team of pharma and biotech people from the United States and Europe. We are grateful to HKSTP for initiating  a survey of the entire Pearl River Delta Region in 2008/09. It is through this initiative that we now see CASiGEN Pharma becoming a reality."

Mr. Anthony Tan, CEO of Hong Kong Science & Technology Parks Corporation (HKSTPC), said that: "We are pleased to have catalyzed the collaboration between an esteemed Chinese Academy of Science Institute and Ventac Partners, resulting in a spinoff company in Hong Kong. HKSTPC provides facilities, services and a dynamic environment that enable companies to nurture ideas, innovate and develop. We look forward to receiving an application from CASiGEN Pharma. CASiGEN Pharma could potentially be an excellent
'/>"/>

SOURCE Ventac Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... , Oct. 2, 2014  MJ Freeway®, the ... two important webinars detailing upcoming legalization efforts in ... and Nevada .  The success of ... of marijuana legalization on the national level. ... and Co-Founder of the Marijuana Policy Project, an organization ...
(Date:10/2/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... conference call to provide an update on the ... Rx in infants and children with spinal ... the morning (CEST) of Friday, October 10 at ... GermanyWhen:Friday, October 10 at 11:30 a.m. ET / ...
(Date:10/1/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... agreement with Patterson Veterinary Supply. Patterson ... of Abaxis veterinary products throughout the United ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
... PAUL, Minn., Feb. 22, 2011 New research shows people ... to be at an increased risk of developing Parkinson,s disease, ... at the American Academy of Neurology ,s 63rd Annual ... Benzedrine and dexedrine are amphetamines often prescribed to increase ...
... Grifols, a global healthcare company and biopharmaceutical manufacturer ... long-term cooperative agreement with the diagnostics business of ... products in the US.  Under the terms of ... immunohematology instruments, assays and other products following US ...
Cached Medicine Technology:Using Amphetamines May Increase Risk of Parkinson's Disease 2Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US 2
(Date:10/2/2014)... When a child, deaf person or elderly ... keep them from wandering off. "In order to eliminate this ... three inventors from Yulee, Fla. , The BUZZ ME helps ... and deters them from wandering off. This avoids stress and ... use and compact, the device can be produced in design ...
(Date:10/2/2014)... 2014 The Business Intelligence Group ... Awards for Business program. The BIG Awards specialize ... proprietary judging process scored by well-known and experienced ... “The winners this year epitomize what is going ... of the Business Intelligence Group. “The sheer amount ...
(Date:10/2/2014)... News) -- Scientists have pinpointed a molecule that may ... The researchers say this finding could offer a ... these attacks. Most asthma attacks (80 percent to ... airways, according to the British researchers. Most of these ... common cold. The researchers found that a specific ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay News) ... -- may face an increased risk of dying in the next ... 3,000 older Americans, researchers found those who were unable to detect ... times as likely to die in the next five years, versus ... -- the inability to distinguish odors -- was a bigger predictor ...
(Date:10/1/2014)... is strongly associated with Alzheimer,s disease; however, researchers are ... the causal agent of the onset and development of ... that beta-amyloid is not harmful when found in isolation ... self-assembles to form the so-called amyloid fibrils , "We ... but with multiple ones because each aggregate of peptide, ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... NEW YORK, March 19 The Department of ... York is a 2009 winner of the American Pain Society,s ... number of pain centers for excellence and innovation in interdisciplinary ... acknowledges the many challenges encountered in maintaining a team of ...
... its recent analysis of the field of orthopedic tissue ... with the 2009 North American Technology Innovation of the ... scaffold for use in orthopedic and spine tissue engineering. ... that it provides a suitable matrix for cell growth ...
... Dr. Friedberg vs. The American Society of Anesthesiologists, Action ... doctor against 43,000 doesn,t seem like very fair odds. ... cosmetic surgery anesthesia, Dr. Barry Friedberg, set the stage ... Society of Anesthesiologists, (ASA) March 9 press release in ...
... Legislative Language to Health Provisions , ... Newport Beach, ... human resource and benefits management services , today released a ... In the face of the significant changes from Barack Obama’s ...
... transcription services to group practices, multi-specialty clinics and community health ... Neurological Associates. , ... Scottsdale, AZ ... provider of medical transcription services to group ...
... ALCMI,s founding organization, the Bonnie J. Addario Lung Cancer ... advertising campaign to raise $20 from one million people in ... CBS Outdoor and friends of the Foundation to raise awareness ... billboards in New York City, Los Angeles, Washington, D.C., San ...
Cached Medicine News:Health News:The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 3Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 4Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 2Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 3Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 2Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: